The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
NK Cells and Cancer
Open accessAbstract
In this review, we overview the main features and functions of NK cells, focusing on their role in cell-mediated immune response to tumor cells. In parallel, we discuss the information available in the field of NK cell receptors and offer a wide general overview of functional aspects of cell targeting and killing, focusing on the recent acknowledgments on the efficacy of NK cells after cytokine and mAb administration in cancer therapy. Since efficacy of NK cell-based immunotherapy has been proven in KIR-mismatch regimens or in TRAIL-dependent apoptosis, the ability to manipulate the balance of activating and inhibitory receptors on NK cells and of their cognate ligands, as well as the sensitivity of tumor cells to apoptosis, opens new perspectives for NK cell-based immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., & McKenna, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1953 · Cited by 1,115
Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., & Caligiuri, M. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1395 · Cited by 1,092
Fernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., & Zitvogel, L. (1999) · Nature Medicine · doi:10.1038/7403 · Cited by 1,060
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis
Chawla-Sarkar, M., Lindner, D. J., Liu, Y.-F., Williams, B. R., Sen, G. C., Silverman, R. H., & Borden, E. C. (2003) · Apoptosis · doi:10.1023/a:1023668705040 · Cited by 829
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
Rosenberg, S. A., Lotze, M. T., Yang, J. C., Topalian, S. L., Chang, A. E., Schwartzentruber, D. J., Aebersold, P., Leitman, S., Linehan, W. M., Seipp, C. A., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.622 · Cited by 639
Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 616
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1455 · Cited by 589
Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., & Perussia, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2375 · Cited by 566
Self-citationRole of chemokines in the biology of natural killer cells
Robertson, M. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.2.173 · Cited by 516
Human natural killer cell development and biology
Farag, S. S., & Caligiuri, M. A. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.10.001 · Cited by 506
Pende, D., Rivera, P., Marcenaro, S., Chang, C., Biassoni, R., Conte, R., Kubin, M. Z., Cosman, D. J., Ferrone, S., Moretta, L., et al. (2002) · PubMed · Cited by 500
Mrozek, E., Anderson, P., & Caligiuri, M. (1996) · Blood · doi:10.1182/blood.v87.7.2632.bloodjournal8772632 · Cited by 492
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., & Caligiuri, M. A. (2002) · Blood · doi:10.1182/blood-2002-02-0350 · Cited by 491
Vosshenrich, C. A. J., García-Ojeda, M. E., Samson-Villéger, S. I., Pasqualetto, V., Enault, L., Goff, O. R.-L., Corcuff, E., Guy-Grand, D., Rocha, B., Cumano, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1395 · Cited by 474
NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
Waldmann, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00091-0 · Cited by 434
Cooper, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.012 · Cited by 434
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer
Smyth, M. J., Teng, M. W. L., Swann, J., Kyparissoudis, K., Godfrey, D. I., & Hayakawa, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1582 · Cited by 420
Zhang, X. D., Franco, A., Myers, K., Gray, C. P., Nguyen, T., & Hersey, P. (1999) · PubMed · Cited by 385
Nature's TRAIL—On a Path to Cancer Immunotherapy
Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R. M., & Yagita, H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00502-2 · Cited by 366
Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H. (2001) · Nature Medicine · doi:10.1038/89050 · Cited by 340
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.001 · Cited by 304
Effector and regulatory events during natural killer–dendritic cell interactions
Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M. C., & Moretta, A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00450.x · Cited by 304
Self-citationIL-21 Induces the Functional Maturation of Murine NK Cells
Brady, J., Hayakawa, Y., Smyth, M. J., & Nutt, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2048 · Cited by 303
NK Cell Compartments and Their Activation by Dendritic Cells
Ferlazzo, G., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1333 · Cited by 299
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Sensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Kobayashi, H., Dubois, S., Sato, N., Sabzevari, H., Sakai, Y., Waldmann, T. A., & Tagaya, Y. (2005) · Blood · doi:10.1182/blood-2003-12-4187 · Cited by 275
IL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response
Strengell, M., Sareneva, T., Foster, D., Julkunen, I., & Matikainen, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3600 · Cited by 250
Lauwerys, B. R., Garot, N., Renauld, J.-C., & Houssiau, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1847 · Cited by 203
NK cells: a lesson from mismatched hematopoietic transplantation
Velardi, A., Ruggeri, L., Alessandro, Moretta, & Moretta, L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02284-6 · Cited by 199
Igarashi, T., Wynberg, J., Srinivasan, R., Becknell, B., McCoy, J. P., Takahashi, Y., Suffredini, D. A., Linehan, W. M., Caligiuri, M. A., & Childs, R. W. (2004) · Blood · doi:10.1182/blood-2003-12-4438 · Cited by 195
Mirandola, P. (2004) · Blood · doi:10.1182/blood-2004-04-1294 · Cited by 188
Self-citationPerforin dependence of natural killer cell‐mediated tumor control in vivo
van den Broek, M. F., Kägi, D., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251246 · Cited by 171
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
Zamai, L., Secchiero, P., Pierpaoli, S., Bassini, A., Papa, S., Alnemri, E. S., Guidotti, L., Vitale, M., & Zauli, G. (2000) · PubMed · doi:10.1182/blood.v95.12.3716 · Cited by 168
Self-citationNKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer
Cerwenka, A., & Lanier, L. L. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00070.x · Cited by 167
Different checkpoints in human NK-cell activation
MORETTA, L., BOTTINO, C., PENDE, D., VITALE, M., MINGARI, M., & MORETTA, A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.008 · Cited by 166
Self-citationIL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215950 · Cited by 164
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Koh, C. Y., Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raziuddin, A., Murphy, W. J., & Bennett, M. (2001) · Blood · doi:10.1182/blood.v97.10.3132 · Cited by 160
Toll-like receptors, inflammation and cancer
Tsan, M. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.004 · Cited by 160
Ross, M. E., & Caligiuri, M. A. (1997) · Blood · doi:10.1182/blood.v89.3.910 · Cited by 153
Pende, D., Bottino, C., Castriconi, R., Cantoni, C., Marcenaro, S., Rivera, P., Spaggiari, G. M., Dondero, A., Carnemolla, B., Reymond, N., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.028 · Cited by 152
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
Tahara‐Hanaoka, S., Shibuya, K., Kai, H., Miyamoto, A., Morikawa, Y., Ohkochi, N., Honda, S.-I., & Shibuya, A. (2005) · Blood · doi:10.1182/blood-2005-04-1684 · Cited by 152
Glas, R., Franksson, L., Une, C., Eloranta, M., Öhlén, C., Örn, A., & Kärre, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.129 · Cited by 146
Seki, N., Brooks, A. D., Carter, C. R. D., Back, T. C., Parsoneault, E. M., Smyth, M. J., Wiltrout, R. H., & Sayers, T. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3484 · Cited by 133
Bennett, I. M., Zatsepina, O. G., Zamai, L., Azzoni, L., Mikheeva, T., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1845 · Cited by 121
Self-citationInterleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets
Roda, J. M., Parihar, R., Lehman, A., Mani, A., Tridandapani, S., & Carson, W. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.120 · Cited by 119
Loza, M. J., Zamai, L., Azzoni, L., Rosati, E., & PERUSSIA, B. (2002) · Blood · doi:10.1182/blood.v99.4.1273 · Cited by 115
Self-citationContrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes
Waldmann, T. A., Dubois, S. P., & Tagaya, Y. (2001) · Immunity · doi:10.1016/s1074-7613(01)00093-0 · Cited by 115
Hietakangas, V., Poukkula, M., Heiskanen, K. M., Karvinen, J. T., Sistonen, L., & Eriksson, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1278-1291.2003 · Cited by 100
Current concepts of tumor-infiltrating lymphocytes in human malignancies
Chiou, S., Sheu, B., Chang, W., Huang, S., & Ho, H. (2005) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2005.06.002 · Cited by 100
Pietro, R. D., Secchiero, P., Rana, R., Gibellini, D., Visani, G., Bemis, K., Zamai, L., Miscia, S., & Zauli, G. (2001) · Blood · doi:10.1182/blood.v97.9.2596 · Cited by 94
Self-citationLearning how to discriminate between friends and enemies, a lesson from Natural Killer cells
Bottino, C., Moretta, L., Pende, D., Vitale, M., & Moretta, A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.004 · Cited by 88
Self-citationMedvedev, A. E., Johnsen, A., Haux, J., Steinkjer, B., Egeberg, K. W., Lynch, D. H., Sundan, A., & Espevik, T. (1997) · Cytokine · doi:10.1006/cyto.1996.0181 · Cited by 88
REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY
Johnsen, A., Haux, J., Steinkjer, B., Nonstad, U., Egeberg, K. W., Sundan, A., Ashkenazi, A., & Espevik, T. (1999) · Cytokine · doi:10.1006/cyto.1999.0489 · Cited by 83
Griffith, T. S., Fialkov, J., Scott, D. L., Azuhata, T., Williams, R. D., Wall, N. R., Altieri, D. C., & Sandler, A. D. (2002) · PubMed · Cited by 79
Sivori, S., Carlomagno, S., Moretta, L., & Moretta, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535781 · Cited by 76
Gehrmann, M., Brunner, M., Pfister, K., Reichle, A., Kremmer, E., & Multhoff, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0382 · Cited by 66
Re, F., Staudacher, C., Zamai, L., Vecchio, V., & Bregni, M. (2006) · Cancer · doi:10.1002/cncr.22002 · Cited by 65
Self-citationNakano, H., Kishida, T., Asada, H., Shin‐Ya, M., Shinomiya, T., Imanishi, J., Shimada, T., Nakai, S., Takeuchi, M., Hisa, Y., et al. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.817 · Cited by 63
Rodella, L. F., Zamai, L., Rezzani, R., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03055.x · Cited by 57
Self-citationINTERLEUKIN 18—INTERFERON γ INDUCING FACTOR—A NOVEL PLAYER IN TUMOUR IMMUNOTHERAPY?
Gołąb, J. (2000) · Cytokine · doi:10.1006/cyto.1999.0563 · Cited by 57
Ng, C., & Bonavida, B. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)85005-9 · Cited by 52
PKCϵ controls protection against TRAIL in erythroid progenitors
Mirandola, P., Gobbi, G., Ponti, C., Sponzilli, I., Cocco, L., & Vitale, M. (2005) · Blood · doi:10.1182/blood-2005-07-2676 · Cited by 48
Self-citationPilla, L., Squarcina, P., Coppa, J. C., Mazzaferro, V., Huber, V., Pende, D., Maccalli, C., Sovena, G., Mariani, L., Castelli, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3493 · Cited by 46
Immunotherapeutic Approaches for Hematologic Malignancies
Caligiuri, M. A., Velardi, A., Scheinberg, D. A., & Borrello, I. (2004) · Hematology · doi:10.1182/asheducation-2004.1.337 · Cited by 43
Chouaı̈b, S., Thiery, J., Gati, A., Guerra, N., Behi, M. E., Dorothée, G., Mami‐Chouaib, F., Bellet, D. H., & Caignard, A. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600401.x · Cited by 38
Cited by
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
NK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Hudak, J. E., Canham, S. M., & Bertozzi, C. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1388 · Cited by 485
Metadata
- Authors
- Zamai, L., Ponti, C., Mirandola, P., Gobbi, G., Papa, S., Galeotti, L., Cocco, L., & Vitale, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-01
- Volume
- 178
- Issue
- 7
- Pages
- 4011-4016
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2167172107
- Cited by
- 292
- References
- 82
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.